Telomir Pharmaceuticals, Inc. · NASDAQ:TELO
John Paul DeJoria, as trustee of the John Paul DeJoria Family Trust, and in his individual capacity reported a 9.44% stake in Telomir Pharmaceuticals, Inc. (Schedule 13G/A)
Event Dec 31, 2025 · Filed Feb 12, 2026
John Paul DeJoria, as trustee of the John Paul DeJoria Family Trust, and in his individual capacity reported a 9.44% stake in Telomir Pharmaceuticals, Inc., 3,245,000 shares, as a passive investor on Dec 31, 2025. Filed Feb 12, 2026 (Schedule 13G/A).
- Stake
- 9.44%
- Shares
- 3,245,000
- Intent
- Passive
- What changed
- Stake changed
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| John Paul DeJoria, as trustee of the John Paul DeJoria Family Trust, and in his individual capacity | 9.44% | 3,245,000 |
Source
Related
- Telomir Pharmaceuticals, Inc.
- John Paul DeJoria, as trustee of the John Paul DeJoria Family Trust, and in his individual capacity
- Telomir Pharmaceuticals, Inc. shareholders
- Schedule 13G/A · John Paul DeJoria, as trustee of the John Paul DeJoria Family Trust, and in his individual capacity · Aug 14, 2026
- Schedule 13G · John Paul DeJoria, as trustee of the John Paul DeJoria Family Trust, and in his individual capacity · Sep 18, 2025
- Form 4 · Aminov Erez · Apr 24, 2026